Niloofar Rahmani

Array ( [id] => 6431276 [patent_doc_number] => 20100143384 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-06-10 [patent_title] => 'NOVEL 4-CYANO, 4-AMINO, AND 4-AMINOMETHYL DERIVATIVES OF PYRAZOLO[1,5-a]PYRIDINES, PYRAZOLO[1,5-c]PYRIMIDINES AND 2H-INDAZOLE COMPOUNDS AND 5-CYANO, 5-AMINO, AND 5-AMINOMETHYL DERIVATIVES OF IMIDAZO[1,2-a]PYRIDINES, AND IMIDAZO[1,5-a]PYRAZINES AS CYCLIN DEPENDENT KINASE INHIBITORS' [patent_app_type] => utility [patent_app_number] => 12/706551 [patent_app_country] => US [patent_app_date] => 2010-02-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 13412 [patent_no_of_claims] => 31 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0143/20100143384.pdf [firstpage_image] =>[orig_patent_app_number] => 12706551 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6560862 [patent_doc_number] => 20100272680 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-10-28 [patent_title] => 'Piperidinyl Cyclic Amido Antiviral Agents' [patent_app_type] => utility [patent_app_number] => 12/702702 [patent_app_country] => US [patent_app_date] => 2010-02-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 63765 [patent_no_of_claims] => 31 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0272/20100272680.pdf [firstpage_image] =>[orig_patent_app_number] => 12702702 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9046888 [patent_doc_number] => 08541442 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-09-24 [patent_title] => 'Indole derivatives as anticancer agents' [patent_app_type] => utility [patent_app_number] => 13/147707 [patent_app_country] => US [patent_app_date] => 2010-02-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 23624 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13147707 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8140899 [patent_doc_number] => 20120094995 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-04-19 [patent_title] => '2-AZA-BICYCLO[2.2.1]HEPTANE COMPOUNDS AND USES THEREOF' [patent_app_type] => utility [patent_app_number] => 13/146461 [patent_app_country] => US [patent_app_date] => 2010-01-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 28451 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0094/20120094995.pdf [firstpage_image] =>[orig_patent_app_number] => 13146461 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7511514 [patent_doc_number] => 20110257224 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-10-20 [patent_title] => 'PREPARATION AND THERAPEUTIC APPLICATIONS OF (2S,3R)-N-2-((3-PYRIDINYL)METHYL)-1-AZABICYCLO[2.2.2]OCT-3-YL)-3,5-DIFLUOROBENZAMIDE' [patent_app_type] => utility [patent_app_number] => 12/740970 [patent_app_country] => US [patent_app_date] => 2010-01-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 24 [patent_figures_cnt] => 24 [patent_no_of_words] => 24073 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 14 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0257/20110257224.pdf [firstpage_image] =>[orig_patent_app_number] => 12740970 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9311845 [patent_doc_number] => 08653063 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-02-18 [patent_title] => 'N-substituted saturated heterocyclic sulfone compounds with CB2 receptor agonistic activity' [patent_app_type] => utility [patent_app_number] => 13/145439 [patent_app_country] => US [patent_app_date] => 2010-01-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 32488 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 7 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13145439 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6517560 [patent_doc_number] => 20100261716 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-10-14 [patent_title] => 'INDAZOLE-CARBOXAMIDE COMPOUNDS AS 5-HT4 RECEPTOR AGONISTS' [patent_app_type] => utility [patent_app_number] => 12/689763 [patent_app_country] => US [patent_app_date] => 2010-01-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 23942 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0261/20100261716.pdf [firstpage_image] =>[orig_patent_app_number] => 12689763 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7523080 [patent_doc_number] => 08026236 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-09-27 [patent_title] => '6-phenyl-1H-imidazo[4,5-c]pyridine-4-carbonitrile derivatives' [patent_app_type] => utility [patent_app_number] => 12/686692 [patent_app_country] => US [patent_app_date] => 2010-01-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 26955 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 18 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/026/08026236.pdf [firstpage_image] =>[orig_patent_app_number] => 12686692 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8386216 [patent_doc_number] => 08263610 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-09-11 [patent_title] => 'Substituted imidazolyl-5,6-dihydrobenzo[N]isoquinoline compounds' [patent_app_type] => utility [patent_app_number] => 12/649762 [patent_app_country] => US [patent_app_date] => 2009-12-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 123627 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 7 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12649762 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7778397 [patent_doc_number] => 20120040951 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-02-16 [patent_title] => 'HETEROARYL COMPOUNDS USEFUL AS RAF KINASE INHIBITORS' [patent_app_type] => utility [patent_app_number] => 13/142603 [patent_app_country] => US [patent_app_date] => 2009-12-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 71370 [patent_no_of_claims] => 49 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0040/20120040951.pdf [firstpage_image] =>[orig_patent_app_number] => 13142603 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6614875 [patent_doc_number] => 20100099643 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-04-22 [patent_title] => 'Fused Pentacyclic Polyethers' [patent_app_type] => utility [patent_app_number] => 12/644238 [patent_app_country] => US [patent_app_date] => 2009-12-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 11261 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0099/20100099643.pdf [firstpage_image] =>[orig_patent_app_number] => 12644238 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9817936 [patent_doc_number] => 08927722 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2015-01-06 [patent_title] => 'Processes and intermediates for preparing a macrocyclic protease inhibitor of HCV' [patent_app_type] => utility [patent_app_number] => 13/141715 [patent_app_country] => US [patent_app_date] => 2009-12-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6672 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13141715 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7685398 [patent_doc_number] => 20100120743 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-05-13 [patent_title] => '11Beta-Hydroxysteroid Dehydrogenase Type 1 Active Compounds' [patent_app_type] => utility [patent_app_number] => 12/640868 [patent_app_country] => US [patent_app_date] => 2009-12-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 21655 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0120/20100120743.pdf [firstpage_image] =>[orig_patent_app_number] => 12640868 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9469259 [patent_doc_number] => 08722891 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-05-13 [patent_title] => 'Conjugate addition reactions using bifunctional Cinchona-alkaloid-based catalysts' [patent_app_type] => utility [patent_app_number] => 13/133438 [patent_app_country] => US [patent_app_date] => 2009-12-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 12761 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 7 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13133438 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8875882 [patent_doc_number] => 08470847 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-06-25 [patent_title] => 'Derivatives of 7-alkynyl-1,8-naphthyridones, preparation method thereof and use of same in therapeutics' [patent_app_type] => utility [patent_app_number] => 12/631122 [patent_app_country] => US [patent_app_date] => 2009-12-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 14768 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12631122 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8386225 [patent_doc_number] => 08263619 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-09-11 [patent_title] => 'Indazoles, benzothiazoles, benzoisothiazoles, benzisoxazoles, and preparation and uses thereof' [patent_app_type] => utility [patent_app_number] => 12/631435 [patent_app_country] => US [patent_app_date] => 2009-12-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 54099 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 11 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12631435 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8386218 [patent_doc_number] => 08263614 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-09-11 [patent_title] => 'Derivatives of 7-alkynyl-1,8-naphthyridones, preparation method thereof and use of same in therapeutics' [patent_app_type] => utility [patent_app_number] => 12/631130 [patent_app_country] => US [patent_app_date] => 2009-12-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6066 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12631130 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6296148 [patent_doc_number] => 20100160369 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-06-24 [patent_title] => 'S1P1 Agonists and Methods of Making And Using' [patent_app_type] => utility [patent_app_number] => 12/630663 [patent_app_country] => US [patent_app_date] => 2009-12-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 112389 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0160/20100160369.pdf [firstpage_image] =>[orig_patent_app_number] => 12630663 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6425871 [patent_doc_number] => 20100168158 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-07-01 [patent_title] => 'MODULATORS OF CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR' [patent_app_type] => utility [patent_app_number] => 12/623626 [patent_app_country] => US [patent_app_date] => 2009-11-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 19852 [patent_no_of_claims] => 38 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0168/20100168158.pdf [firstpage_image] =>[orig_patent_app_number] => 12623626 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8410339 [patent_doc_number] => 08273736 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-09-25 [patent_title] => 'Thienopyridine and furopyridine kinase inhibitors' [patent_app_type] => utility [patent_app_number] => 12/623026 [patent_app_country] => US [patent_app_date] => 2009-11-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 172142 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12623026 [rel_patent_id] =>[rel_patent_doc_number] =>)